Skip to main content

Table 2 Outcomes of sensitivity analysis

From: Does metabolic dysfunction-associated fatty liver disease increase the risk of chronic kidney disease? A meta-analysis of cohort studies

Study excluded

Resultant hazard ratio [95% confidence intervals]

Gao 2024 [17]

1.42 [1.27, 1.58]

Hashimoto 2022 [19]

1.39 [1.24, 1.56]

Jung 2022 [20]

1.38 [1.22, 1.56]

Kwon 2023 [22]

1.34 [1.20, 1.49]

Liang 2022 [21]

1.35 [1.21, 1.51]

Tanaka 2023 [18]

1.42 [1.26, 1.59]

Wei 2023 [23]

1.41 [1.25, 1.60]

Zhang 2023 [24]

1.37 [1.22, 1.53]

Zhang 2023’[24]

1.33 [1.20, 1.47]